Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study. (Q38463163)
Jump to navigation
Jump to search
scientific article published on 05 October 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study. |
scientific article published on 05 October 2012 |
Statements
Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study (English)
M Mabro
B Chibaudel
C Tournigand
P Artru
S Nguyen
C Ebenezer
N Aissat
A de Gramont
GERCOR
F Penault-Llorca
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference